Evidence map›Paper›PMID 32805300›Full record

ReviewInternational journal of radiation oncology, biology, physics2021

Current Status of Radiopharmaceutical Therapy.

Sara St James, Bryan Bednarz, Stanley Benedict, Jeffrey C Buchsbaum, Yuni Dewaraja, Eric Frey, Robert Hobbs, Joseph Grudzinski, Emilie Roncali, George Sgouros and 2 more

Open access · greenAbstract readReview
In one paragraph

Review in International journal of radiation oncology, biology, physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 114 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Convection enhanced delivery of Rhenium (Nature communications · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Sara St JamesDepartment of Radiation Oncology, University of California San Francisco, San Francisco, California. Electronic address: sara.st.james@ucsf.edu.
Bryan BednarzDepartment of Medical Physics and Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Stanley BenedictDepartment of Radiation Oncology, University of California Davis, Sacramento, California.
Jeffrey C BuchsbaumRadiation Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, Maryland.
Yuni DewarajaDepartment of Radiology, University of Michigan, Ann Arbor, Michigan.
Eric FreyDepartment of Radiology, Johns Hopkins University, Baltimore, Maryland.
Robert HobbsDepartment of Radiology, Johns Hopkins University, Baltimore, Maryland.
Joseph GrudzinskiVoximetry Inc.
Emilie RoncaliDepartment of Radiation Oncology, University of California Davis, Sacramento, California.
George SgourosDepartment of Radiology, Johns Hopkins University, Baltimore, Maryland.
Jacek CapalaRadiation Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, Maryland.
Ying XiaoHospital of the University of Pennsylvania.
Johns Hopkins University · USCenter for Cancer Research · USUniversity of California, Davis · USHospital of the University of Pennsylvania · USUniversity of California, San Francisco · USUniversity of Michigan–Ann Arbor · USUniversity of Wisconsin–Madison · US

Funding

NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8M
IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
NCI NIH HHS U10 CA180868NCI NIH HHS U24 CA180803
6 · The paper itself

Abstract

In radiopharmaceutical therapy (RPT), a radionuclide is systemically or locally delivered with the goal of targeting and delivering radiation to cancer cells while minimizing radiation exposure to untargeted cells. Examples of current RPTs include thyroid ablation with the administration of

Indexed as

CalibrationClinical Trials as TopicHumansNeoplasmsPositron-Emission TomographyRadiopharmaceuticalsRadiotherapy DosageRadiotherapy, Image-GuidedSingle Photon Emission Computed Tomography Computed TomographyRadiopharmaceuticals

Identifiers

PMID32805300
PMCPMC8422258
OpenAlexW3049728153

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.